In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pliva acquires Sidmak and Odyssey

Executive Summary

Croatian pharmaceutical company Pliva acquired Sobel's US-based Sidmak Laboratories (generics) along with Sidmak's wholly owned subsidiary Odyssey Pharmaceuticals (branded pharmaceuticals) for a total of Euro231.4mm ($211.9mm)--consisting of $152.9 in cash and $59mm in debt.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies